Trial Profile
An Observational study to evaluate the risk of fracture after Denosumab discontinuation in patients from Medicare administrative claims database
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 13 Jan 2017 New trial record